Gastroenterologia y hepatologia最新文献_第7页

Sustained jaundice after endoscopic retrograde cholangiopancreatography. 内镜逆行胰胆管造影术后持续黄疸。内镜逆行胰胆管造影术后持续黄疸。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-10 DOI: 10.1016/j.gastrohep.2024.502264

Idoia Agulleiro Beraza, Eduardo Leo Carnerero, José Manuel Sousa Martín, Rose Marie Vallejo Vigo

引用次数: 0

Cambio de pauta de intensificación de infliximab en pacientes con enfermedad inflamatoria intestinal en remisión mantenida. Reflexiones a propósito de una serie de casos 持续缓解的炎症性肠病患者英夫利西单抗强化治疗方案的变化：对一系列病例的思考。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2023.07.004

引用次数: 0

Diagnosis of eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis in adults. A brief review 成人嗜酸性粒细胞食管炎之外的嗜酸性粒细胞胃肠道疾病诊断。简要回顾。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2024.04.003

Esteban Fuentes-Valenzuela , Pedro Delgado-Guillena , Raúl Velamazan-Sandalinas , Javier Jiménez Sánchez , Natalia García-Morales , Jesús Barrio , Alfredo J Lucendo

引用次数: 0

Beaver tail liver 海狸尾肝

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2023.08.007

引用次数: 0

Malignant transformation in fistula after proctosigmoidectomy: A rare complication of long-standing Crohn's disease 直肠乙状结肠切除术后瘘管的恶性转化：久治不愈的克罗恩病的罕见并发症

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2024.01.012

引用次数: 0

A meta-analysis of Lactate Ringer's solution versus Normal Saline in the treatment of acute pancreatitis 乳酸林格氏液与正常生理盐水治疗急性胰腺炎的荟萃分析。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2023.12.007

引用次数: 0

Documento de puesta al día de la Asociación Española de Neurogastroenterología y Motilidad (ASENEM) sobre el manejo del dolor abdominal funcional 西班牙神经胃肠病学与运动协会（Asociación española de neurogastroenterologia y motilidad，ASENEM）关于功能性腹痛治疗的最新综述。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2024.02.005

引用次数: 0

Influence of HLA-DQA1*05 on the loss of response to anti-TNF treatment in inflammatory bowel disease. Spanish cohort of real clinical practice HLA-DQA1∗05对炎症性肠病患者抗肿瘤坏死因子治疗无效的影响。西班牙真实临床实践队列。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2024.01.005

引用次数: 0

Incidence and prevalence of inflammatory bowel diseases in a population from Buenos Aires, Argentina 阿根廷布宜诺斯艾利斯市炎症性肠病的发病率和流行率。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2023.09.012

{"title":"Incidence and prevalence of inflammatory bowel diseases in a population from Buenos Aires, Argentina","authors":"","doi":"10.1016/j.gastrohep.2023.09.012","DOIUrl":"10.1016/j.gastrohep.2023.09.012","url":null,"abstract":"<div><h3>Background</h3><div>Inflammatory bowel diseases (IBD) incidence and prevalence in Latin America have experienced a significant shift in the last decades. There is paucity of IBD epidemiologic data in Argentina.</div></div><div><h3>Aim</h3><div>To determine the incidence and prevalence of IBD between 2018 and 2022 of a population from the city of Buenos Aires.</div></div><div><h3>Materials and methods</h3><div>From January 1st, 2018 to December 31st, 2022, the total population of two healthcare insurances were studied. ‘Possible’ IBD cases were identified using the following information sources: IBD-unit patient databases; electronic medical record; central laboratory electronic database; histopathology electronic database; pharmacy electronic database. Age-adjusted incidence and prevalence rates for Crohn's disease (CD), ulcerative colitis (UC) and IBD were estimated based on the number of patients compared with the at-risk population and expressed per 100,000 subjects. Trends in IBD incidence and prevalence were estimated as annual percentage changes; we used Poisson regression modeling to calculate significance in these trends over time.</div></div><div><h3>Results</h3><div>Information source analysis rendered 172 possible cases, of which 82 cases of IBD were finally confirmed: 27.16% were CD and 72.84% were UC. Mean age-standardized incidence across the study period for IBD, CD and UC was 11.93 (11.28–12.55), 2.88 (2.65–3.07) and 9.05 (8.83–9.2) respectively. Point prevalence on December 31st, 2022 for IBD, UC and CD was 134 (95%CI 132.3–135.6), 98 (96.95–99.52) and 36 (35.69–36.4) respectively.</div></div><div><h3>Conclusions</h3><div>We found an incidence and prevalence of IBD in a population from Buenos Aires higher than those previously published in epidemiological studies in Argentina.</div></div>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"47 8","pages":"Pages 804-812"},"PeriodicalIF":2.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41112892","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Biological therapy, surgery, and hospitalization rates for inflammatory bowel disease: An observational Latin American comparative study between adults and pediatric patients 炎症性肠病的生物治疗、手术和住院率：一项拉丁美洲成人和儿童患者的观察性比较研究。

IF 2.2 4区医学

Gastroenterologia y hepatologia Pub Date : 2024-10-01 DOI: 10.1016/j.gastrohep.2023.10.006

{"title":"Biological therapy, surgery, and hospitalization rates for inflammatory bowel disease: An observational Latin American comparative study between adults and pediatric patients","authors":"","doi":"10.1016/j.gastrohep.2023.10.006","DOIUrl":"10.1016/j.gastrohep.2023.10.006","url":null,"abstract":"<div><h3>Objective</h3><div>Compare the proportions of use of biological therapy, surgeries, and hospitalizations between adults and pediatric inflammatory bowel disease (IBD)—Crohn's disease (CD) and ulcerative colitis (UC)—patients.</div></div><div><h3>Patients and methods</h3><div>Observational, retrospective, and multicenter study. Data were collected from all consecutive IBD patients seen as outpatients or admitted to hospital, during 2015–2021, in two IBD tertiary centers in a South Brazilian capital. Patients with unclassified colitis diagnosis were excluded from this study. Patients were classified as having CD or UC and sub-categorized as adult or pediatric according to age. Data were analyzed using frequency, proportion, Fisher's exact test, and Chi-square test.</div></div><div><h3>Results</h3><div>A total of 829 patients were included: 509 with CD (378 adults/131 pediatric) and 320 with UC (225/95). Among patients with CD, no differences were observed for proportions of use of biological therapy (80.2% in pediatric vs. 73.3% in adults; <em>P</em>  =0.419), or hospitalization (64.9% vs. 56.9%; <em>P</em>  =0.048) and hospitalization (47.4% vs. 24.0%; <em>P</em>  =0.219).</div></div><div><h3>Conclusions</h3><div>Biological therapy and incidence of hospitalization were greater among pediatric patients with UC, compared with adults; no difference was observed in the need for abdominal surgery. In CD, no significant difference was observed in the three main outcomes between the age groups.</div></div>","PeriodicalId":12802,"journal":{"name":"Gastroenterologia y hepatologia","volume":"47 8","pages":"Pages 813-820"},"PeriodicalIF":2.2,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61562033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0